Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes.

Efird JT, Choi YM, Davies SW, Mehra S, Anderson EJ, Katunga LA.

Int J Environ Res Public Health. 2014 Feb 21;11(2):2328-45. doi: 10.3390/ijerph110202328. Review.

2.

Bitter melon (Momordica charantia): a review of efficacy and safety.

Basch E, Gabardi S, Ulbricht C.

Am J Health Syst Pharm. 2003 Feb 15;60(4):356-9. Review.

PMID:
12625217
3.

Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.

Inayat-ur-Rahman, Malik SA, Bashir M, Khan R, Iqbal M.

Phytomedicine. 2009 May;16(5):401-5. doi: 10.1016/j.phymed.2009.01.001. Epub 2009 Apr 10.

PMID:
19362455
4.

Momordica charantia for type 2 diabetes mellitus.

Ooi CP, Yassin Z, Hamid TA.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD007845. doi: 10.1002/14651858.CD007845.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD007845.

PMID:
20166099
5.

Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.

Uebanso T, Arai H, Taketani Y, Fukaya M, Yamamoto H, Mizuno A, Uryu K, Hada T, Takeda E.

J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):482-8.

6.

Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.

Fuangchan A, Sonthisombat P, Seubnukarn T, Chanouan R, Chotchaisuwat P, Sirigulsatien V, Ingkaninan K, Plianbangchang P, Haines ST.

J Ethnopharmacol. 2011 Mar 24;134(2):422-8. doi: 10.1016/j.jep.2010.12.045. Epub 2011 Jan 4.

PMID:
21211558
7.

[Bitter melon to control high blood sugar].

[No authors listed]

Praxis (Bern 1994). 2004 Dec 8;93(50):2118. German. No abstract available.

PMID:
15646680
8.

Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.

Shih CC, Lin CH, Lin WL, Wu JB.

J Ethnopharmacol. 2009 May 4;123(1):82-90. doi: 10.1016/j.jep.2009.02.039. Epub 2009 Mar 6.

PMID:
19429344
9.

A review of the hypoglycemic effects of five commonly used herbal food supplements.

Deng R.

Recent Pat Food Nutr Agric. 2012 Apr 1;4(1):50-60. Review.

10.

Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.

Krawinkel MB, Keding GB.

Nutr Rev. 2006 Jul;64(7 Pt 1):331-7. Review.

PMID:
16910221
11.

Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.

Miura T, Itoh Y, Iwamoto N, Kato M, Ishida T.

Biol Pharm Bull. 2004 Feb;27(2):248-50.

12.

Momordica charantia for type 2 diabetes mellitus.

Ooi CP, Yassin Z, Hamid TA.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007845. doi: 10.1002/14651858.CD007845.pub3. Review.

PMID:
22895968
13.

Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.

Yang SJ, Choi JM, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY.

J Nutr Biochem. 2015 Mar;26(3):234-40. doi: 10.1016/j.jnutbio.2014.10.010. Epub 2014 Nov 22.

PMID:
25488547
14.

Complementary and alternative medicine for the treatment of type 2 diabetes.

Nahas R, Moher M.

Can Fam Physician. 2009 Jun;55(6):591-6. Review.

15.

Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.

Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S.

Br J Nutr. 2009 Dec;102(12):1703-8. doi: 10.1017/S0007114509992054. Review.

PMID:
19825210
16.

Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet.

Shih CC, Lin CH, Lin WL.

Diabetes Res Clin Pract. 2008 Aug;81(2):134-43. doi: 10.1016/j.diabres.2008.04.023. Epub 2008 Jun 11.

PMID:
18550200
17.

Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.

Snee LS, Nerurkar VR, Dooley DA, Efird JT, Shovic AC, Nerurkar PV.

Nutr J. 2011 Jul 28;10:78. doi: 10.1186/1475-2891-10-78. Erratum in: Nutr J. 2014;13:3.

18.

Momordica charantia and type 2 diabetes: from in vitro to human studies.

Habicht SD, Ludwig C, Yang RY, Krawinkel MB.

Curr Diabetes Rev. 2014 Jan;10(1):48-60. Review.

PMID:
24295371
19.

A case of atrial fibrillation due to Momordica charantia (bitter melon).

Erden I, Ordu S, Erden EC, Caglar SO.

Ann Saudi Med. 2010 Jan-Feb;30(1):86-7. doi: 10.4103/0256-4947.59372. No abstract available.

20.

[Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus III. Momordica (Momordica charantia)].

Rudá-Kučerová J, Kotolová H, Koupý D.

Ceska Slov Farm. 2015 Sep;64(4):126-32. Czech.

PMID:
26459126

Supplemental Content

Support Center